Latest filing published 13 Jul 2018 for Navidea Biopharmaceuticals, INC., €42k.
Insider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Frederick O. Cope: trading record in brief
Frederick O. Cope discloses dealings in Navidea Biopharmaceuticals, Inc. to SEC (Form 4). Between 17 November 2010 and 29 June 2018, the trades on record add up to 8 filings.
Market trades split into 2 purchases (€10k) and 1 sale (€21k). Sales outweigh purchases by €11k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 5 share grants.
The newest entry dates from 13 July 2018: a share grant of €42k, in Navidea Biopharmaceuticals, Inc. The clock since the last published purchase (8 November 2013) now reads 4,749 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Frederick O. Cope
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 212,390 shares@ US$0.2351.7% of flowCommon StockSEC:0001437749-18-013286:0
- 135,694 shares@ US$0.3631.7% of flowCommon StockSEC:0001437749-18-003132:0
- 88,378 shares@ US$0.5234.3% of flowNAVB Common Stock, $.001 par valueSEC:0001144204-17-006945:0
- 15,000 shares@ US$1.96Common StockSEC:0001225208-14-008076:0
- 3,500 shares@ US$1.43Common StockSEC:0001225208-13-023152:0Canonical exit: 6 Feb 2014 (T+90)
- 125,000 shares0Common StockSEC:0001225208-13-007799:0
- 42,686 shares@ US$3.16Common StockSEC:0001225208-13-007799:1
- 5,000 shares@ US$1.76Common StockSEC:0001225208-10-025207:0Canonical exit: 15 Feb 2011 (T+90)
8 of 8 declarations